Stay updated with breaking news from Pre Conference Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop, commercialize, and manufacture...
Milwaukee, WI (PRWEB) May 11, 2023 -- TheSociety for Immunotherapy of Cancer (SITC) is excited to announce Susan Kaech, PhD, from Salk Institute as the
/PRNewswire/ -- Thousands of pediatric researchers, clinical care providers, and leaders in pediatric academics from across the globe will gather in...
Milwaukee, WI (PRWEB) November 02, 2022 -- The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2022,
/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying...